Literature DB >> 23747047

Association between PARK16 and Parkinson's disease in the Han Chinese population: a meta-analysis.

Kuo-Hsuan Chang1, Chiung-Mei Chen, Yi-Chun Chen, Rong-Kuo Lyu, Hong-Shiu Chang, Long-Sun Ro, Guey-Jen Lee-Chen, Yih-Ru Wu.   

Abstract

PARK16 was reported to alter the risk for Parkinson's disease (PD) in the Japanese population. However, its role in Han Chinese PD patients has not been well established. Herein, we investigated the effect of 4 single-nucleotide polymorphisms (SNPs) within the PARK16 locus, including rs823128, rs947211, rs823156, and rs11240572, on the risk of PD by genotyping 497 Taiwanese patients with PD and 500 age-matched control subjects. The results were then meta-analyzed with available genetic association studies in the same population. The meta-analysis showed that PD patients demonstrated a lower frequency of the rs823128 G allele (11.93%) than control subjects (14.04%; odds ratio [OR] 0.83, 95% confidence interval [CI] 0.72-0.96, p = 0.010). The frequency of the rs947211 A allele (40.35%) in PD patients was lower than in control subjects (43.01%; OR 0.90, 95% CI 0.80-0.99, p = 0.047). The rs823156 G allele was less frequently seen in PD patients (17.32%) than in control subjects (21.35%; OR 0.77, 95% CI 0.69-0.86, p < 0.001). A lower frequency of the rs11240572 A allele was found in PD patients (14.01%) than in control subjects (17.66%; OR 0.76, 95% CI 0.66-0.88, p < 0.001). Our results indicate a robust protective effect of PARK16 in Han Chinese PD patients. Functional approaches are needed to elucidate the effects of these SNPs on the regulation of gene expression.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Disease association; PARK16; Parkinson's disease; Polymorphism

Mesh:

Year:  2013        PMID: 23747047     DOI: 10.1016/j.neurobiolaging.2013.04.028

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  2 in total

1.  Associations of rs823128, rs1572931, and rs823156 polymorphisms with reduced Parkinson's disease risks.

Authors:  Ye Bai; Lihong Dong; Xinghua Huang; Shuanglin Zheng; Ping Qiu; Fenghua Lan
Journal:  Neuroreport       Date:  2017-09-27       Impact factor: 1.837

2.  Parkinson's disease GWAS-linked Park16 carriers show greater motor progression.

Authors:  Xiao Deng; Bin Xiao; John Carson Allen; Ebonne Ng; Jia Nee Foo; Yew-Long Lo; Louis C S Tan; Eng-King Tan
Journal:  J Med Genet       Date:  2019-02-27       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.